{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:04:31Z","timestamp":1791615871039,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45845-y","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T21:25:05Z","timestamp":1775424305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of natural FGFR3 inhibitor for glioma using integrated computational and microRNA regulatory analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Shehla","family":"Javaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiah","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamamd Nouman","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"key":"45845_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41420-025-02542-5","volume":"11","author":"P Deshors","year":"2025","unstructured":"Deshors, P., Kheil, Z., Ligat, L. & Gouaz\u00e9-Andersson, V. Cohen-Jonathan Moyal, E. FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields. Cell. Death Discovery. 11, 265. https:\/\/doi.org\/10.1038\/s41420-025-02542-5 (2025).","journal-title":"Cell. Death Discovery"},{"key":"45845_CR2","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.3390\/ijms26062723","volume":"26","author":"S Epistolio","year":"2025","unstructured":"Epistolio, S. et al. The Clinical Role of miRNAs in the Development and Treatment of Glioblastoma. Int. J. Mol. Sci. 26, 2723 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"45845_CR3","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp, R. et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA 318, 2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718 (2017).","journal-title":"JAMA"},{"key":"45845_CR4","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp, R. et al. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. JAMA 314, 2535\u20132543. https:\/\/doi.org\/10.1001\/jama.2015.16669 (2015).","journal-title":"JAMA"},{"key":"45845_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11060-018-03015-9","volume":"140","author":"M Ijzerman-Korevaar","year":"2018","unstructured":"Ijzerman-Korevaar, M., Snijders, T. J., de Graeff, A., Teunissen, S. C. C. M. & de Vos, F. Y. F. Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J. Neurooncol. 140, 485\u2013496. https:\/\/doi.org\/10.1007\/s11060-018-03015-9 (2018).","journal-title":"J. Neurooncol."},{"key":"45845_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.celrep.2017.10.030","volume":"21","author":"S Darmanis","year":"2017","unstructured":"Darmanis, S. et al. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma. Cell. Rep. 21, 1399\u20131410. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.030 (2017).","journal-title":"Cell. Rep."},{"key":"45845_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.1220834","volume":"337","author":"D Singh","year":"2012","unstructured":"Singh, D. et al. Transforming Fusions of <\u2009i>FGFR and TACC Genes in Human Glioblastoma. Science 337, 1231\u20131235. https:\/\/doi.org\/10.1126\/science.1220834 (2012).","journal-title":"Science"},{"key":"45845_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/cimb47070498","volume":"47","author":"F Alrumaihi","year":"2025","unstructured":"Alrumaihi, F., Rahmani, A. H., Prabhu, S. V., Kumar, V. & Anwar, S. The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer. Curr. Issues. Mol. Biol. 47, 498 (2025).","journal-title":"Curr. Issues. Mol. Biol."},{"key":"45845_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","volume":"17","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. Targeting FGFR for cancer therapy. J. Hematol. Oncol. 17, 39. https:\/\/doi.org\/10.1186\/s13045-024-01558-1 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"45845_CR10","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.3390\/ijms23158675","volume":"23","author":"H G\u00f6tt","year":"2022","unstructured":"G\u00f6tt, H. & Uhl, E. FGFR3-TACCs3 Fusions and Their Clinical Relevance in Human Glioblastoma. Int. J. Mol. Sci. 23, 8675 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"45845_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40478-021-01170-1","volume":"9","author":"MM Georgescu","year":"2021","unstructured":"Georgescu, M. M., Islam, M. Z., Li, Y., Traylor, J. & Nanda, A. Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs. Acta Neuropathol. Commun. 9, 69. https:\/\/doi.org\/10.1186\/s40478-021-01170-1 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"45845_CR12","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ptr.5669","volume":"30","author":"S Safe","year":"2016","unstructured":"Safe, S. & Kasiappan, R. Natural Products as Mechanism-based Anticancer Agents: Sp Transcription Factors as Targets. Phytother. Res. 30, 1723\u20131732. https:\/\/doi.org\/10.1002\/ptr.5669 (2016).","journal-title":"Phytother. Res."},{"key":"45845_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12986-017-0180-8","volume":"14","author":"AA Bhat","year":"2017","unstructured":"Bhat, A. A. et al. Potential therapeutic targets of Guggulsterone in cancer. Nutr. Metabolism. 14, 23. https:\/\/doi.org\/10.1186\/s12986-017-0180-8 (2017).","journal-title":"Nutr. Metabolism"},{"key":"45845_CR14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1172\/JCI67144","volume":"123","author":"BC Parker","year":"2013","unstructured":"Parker, B. C. et al. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J. Clin. Investig. 123, 855\u2013865. https:\/\/doi.org\/10.1172\/JCI67144 (2013).","journal-title":"J. Clin. Investig."},{"key":"45845_CR15","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2147\/ott.S85677","volume":"8","author":"Y Luan","year":"2015","unstructured":"Luan, Y., Zhang, S., Zuo, L. & Zhou, L. Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3. Onco Targets Ther. 8, 3391\u20133400. https:\/\/doi.org\/10.2147\/ott.S85677 (2015).","journal-title":"Onco Targets Ther."},{"key":"45845_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.37349\/etat.2020.00019","volume":"1","author":"S Girisa","year":"2020","unstructured":"Girisa, S., Parama, D., Harsha, C., Banik, K. & Kunnumakkara, A. B. Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer. Explor. Target. Antitumor Ther. 1, 313\u2013342. https:\/\/doi.org\/10.37349\/etat.2020.00019 (2020).","journal-title":"Explor. Target. Antitumor Ther."},{"key":"45845_CR17","doi-asserted-by":"publisher","first-page":"115855","DOI":"10.1016\/j.jep.2022.115855","volume":"301","author":"HB Xu","year":"2023","unstructured":"Xu, H. B., Chen, X. Z., Yu, Z. L. & Xue, F. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR\/PI3K\/Akt signaling and NF-\u03baB activation. J. Ethnopharmacol. 301, 115855. https:\/\/doi.org\/10.1016\/j.jep.2022.115855 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"45845_CR18","doi-asserted-by":"publisher","unstructured":"Gurung, A. B., Ali, M. A., Lee, J., Farah, M. A. & Al-Anazi, K. M. An updated review of computer-aided drug design and its application to COVID-19. BioMed Res. Int. 8853056. https:\/\/doi.org\/10.1155\/2021\/8853056 (2021).","DOI":"10.1155\/2021\/8853056"},{"key":"45845_CR19","doi-asserted-by":"publisher","first-page":"115855","DOI":"10.1016\/j.jep.2022.115855","volume":"301","author":"HB Xu","year":"2023","unstructured":"Xu, H. B., Chen, X. Z., Yu, Z. L. & Xue, F. Guggulsterone from Commiphora mukul potentiates anti-glioblastoma efficacy of temozolomide in vitro and in vivo via down-regulating EGFR\/PI3K\/Akt signaling and NF-\u03baB activation. J. Ethnopharmacol. 301, 115855. https:\/\/doi.org\/10.1016\/j.jep.2022.115855 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"45845_CR20","doi-asserted-by":"crossref","unstructured":"Velankar, S., Burley, S. K., Kurisu, G., Hoch, J. C. & Markley, J. L. The protein data bank archive. Struct. Proteom. High Throughput Methods 3\u201321 (2021).","DOI":"10.1007\/978-1-0716-1406-8_1"},{"key":"45845_CR21","doi-asserted-by":"publisher","first-page":"1493165","DOI":"10.3389\/fchem.2024.1493165","volume":"12","author":"M Hussain","year":"2024","unstructured":"Hussain, M. et al. Computational modeling of cyclotides as antimicrobial agents against Neisseria gonorrhoeae PorB porin protein: integration of docking, immune, and molecular dynamics simulations. Front. Chem. 12, 1493165 (2024).","journal-title":"Front. Chem."},{"key":"45845_CR22","doi-asserted-by":"publisher","first-page":"26405","DOI":"10.1038\/s41598-024-77664-4","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy. Sci. Rep. 14, 26405 (2024).","journal-title":"Sci. Rep."},{"key":"45845_CR23","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2, 1511\u20131519 (1993).","journal-title":"Protein Sci."},{"key":"45845_CR24","doi-asserted-by":"publisher","first-page":"btae552","DOI":"10.1093\/bioinformatics\/btae552","volume":"40","author":"F Mehryary","year":"2024","unstructured":"Mehryary, F., Nastou, K., Ohta, T., Jensen, L. J. & Pyysalo, S. STRING-ing together protein complexes: corpus and methods for extracting physical protein interactions from the biomedical literature. Bioinformatics 40, btae552 (2024).","journal-title":"Bioinformatics"},{"key":"45845_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1142\/S2737416523500631","volume":"23","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. Assessment of Melia azedarach plant extracts activity against hypothetical protein of mycobacterium tuberculosis via GC-MS analysis and in-silico approaches. J. Comput. Biophys. Chem. 23, 299\u2013320 (2024).","journal-title":"J. Comput. Biophys. Chem."},{"key":"45845_CR26","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202\u2013D1213 (2016).","journal-title":"Nucleic Acids Res."},{"key":"45845_CR27","doi-asserted-by":"crossref","unstructured":"Rahman, S. U. et al. Innovative phytochemicals based in-silico drug design and molecular dynamics simulation targeting norovirus induced gastroenteritis. J. Mol. Struct. 141733 (2025).","DOI":"10.1016\/j.molstruc.2025.141733"},{"key":"45845_CR28","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"45845_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-024-51954-3","volume":"14","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. The natural breakthrough: Phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3. Sci. Rep. 14, 1529 (2024).","journal-title":"Sci. Rep."},{"key":"45845_CR30","doi-asserted-by":"crossref","unstructured":"Pol\u00e1k, L. et al. PrankWeb 4: a modular web server for protein\u2013ligand binding site prediction and downstream analysis. Nucleic Acids Res. gkaf421 (2025).","DOI":"10.1093\/nar\/gkaf421"},{"key":"45845_CR31","doi-asserted-by":"crossref","unstructured":"Ali, N., Asrar, B. & Ahmad, S. A. I. Fragment based optimization of saffron and chamomile phytochemicals as aryl hydrocarbon receptor inhibitors for dementia therapy an integrated computational approach. Comput. Biol. Chem. 108606 (2025).","DOI":"10.1016\/j.compbiolchem.2025.108606"},{"key":"45845_CR32","unstructured":"Jejurikar, B. L. & Rohane, S. H. Drug designing in discovery studio. (2021)."},{"key":"45845_CR33","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"N Guex","year":"2009","unstructured":"Guex, N., Peitsch, M. C. & Schwede, T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss\u2010PdbViewer: A historical perspective. Electrophoresis 30, S162\u2013S173 (2009).","journal-title":"Electrophoresis"},{"key":"45845_CR34","unstructured":"Pawar, R. P. & Rohane, S. H. Role of autodock vina in PyRx molecular docking. (2021)."},{"key":"45845_CR35","doi-asserted-by":"publisher","first-page":"15906","DOI":"10.1038\/s41598-025-00937-z","volume":"15","author":"M Naveed","year":"2025","unstructured":"Naveed, M. et al. Exploring the therapeutic potential of Thymus vulgaris ethanol extract: a computational screening for antimicrobial compounds against COVID-19 induced mucormycosis. Sci. Rep. 15, 15906 (2025).","journal-title":"Sci. Rep."},{"key":"45845_CR36","doi-asserted-by":"publisher","unstructured":"Schake, P., Bolz, S. N., Linnemann, K. & Schroeder, M. PLIP 2025: introducing protein\u2013protein interactions to the protein\u2013ligand interaction profiler. Nucleic Acids Res. 53 (W463-W465). https:\/\/doi.org\/10.1093\/nar\/gkaf361 (2025).","DOI":"10.1093\/nar\/gkaf361"},{"key":"45845_CR37","first-page":"e1298","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan, S., Chan, H. S. & Hu, Z. Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Comput. Mol. Sci. 7, e1298 (2017).","journal-title":"Wiley Interdisciplinary Reviews: Comput. Mol. Sci."},{"key":"45845_CR38","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1021\/acs.jcim.5c01063","volume":"65","author":"DA Case","year":"2025","unstructured":"Case, D. A. et al. Recent Developments in Amber Biomolecular Simulations. J. Chem. Inf. Model. 65, 7835\u20137843. https:\/\/doi.org\/10.1021\/acs.jcim.5c01063 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"45845_CR39","doi-asserted-by":"publisher","first-page":"13055","DOI":"10.1039\/D1CP00215E","volume":"23","author":"S Kashefolgheta","year":"2021","unstructured":"Kashefolgheta, S., Wang, S., Acree, W. E. & H\u00fcnenberger, P. H. Evaluation of nine condensed-phase force fields of the GROMOS, CHARMM, OPLS, AMBER, and OpenFF families against experimental cross-solvation free energies. Phys. Chem. Chem. Phys. 23, 13055\u201313074 (2021).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"45845_CR40","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.jiph.2023.07.011","volume":"16","author":"M Zaheer","year":"2023","unstructured":"Zaheer, M., Ali, N., Javed, H., Munir, R. & Jamil, N. Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach. J. Infect. Public Health. 16, 1544\u20131555 (2023).","journal-title":"J. Infect. Public Health"},{"key":"45845_CR41","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.1038\/s41598-025-96989-2","volume":"15","author":"M Naveed","year":"2025","unstructured":"Naveed, M. et al. Computational design of a glycosylated multi-epitope vaccine against HAsV-1 and HAsV-2 astrovirus for acute gastroenteritis. Sci. Rep. 15, 13954 (2025).","journal-title":"Sci. Rep."},{"key":"45845_CR42","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/prot.26077","volume":"89","author":"PP Venugopal","year":"2021","unstructured":"Venugopal, P. P., Chakraborty, D. & M, S. & Theoretical insights into molecular mechanism and energy criteria of PARP-2 enzyme inhibition by benzimidazole analogues. Proteins Struct. Funct. Bioinform. 89, 988\u20131004. https:\/\/doi.org\/10.1002\/prot.26077 (2021).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"45845_CR43","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/prot.26793","volume":"93","author":"AR Choudhury","year":"2025","unstructured":"Choudhury, A. R., Gaikwad, V., Maity, A. & Chakrabarti, R. Exploring the Effect of Hydrocarbon Cross-Linkers on the Structure and Binding of Stapled p53 Peptides. Proteins Struct. Funct. Bioinform. 93, 1090\u20131106. https:\/\/doi.org\/10.1002\/prot.26793 (2025).","journal-title":"Proteins Struct. Funct. Bioinform."},{"issue":"1\u20133","key":"45845_CR44","first-page":"6","volume":"62, 3","author":"DR Koes","year":"2018","unstructured":"Koes, D. R. The Pharmit backend: a computer systems approach to enabling interactive online drug discovery. IBM J. Res. Dev. 62, 3: (1\u20133), 6 (2018).","journal-title":"IBM J. Res. Dev."},{"key":"45845_CR45","doi-asserted-by":"publisher","first-page":"24906","DOI":"10.1038\/s41598-025-07574-6","volume":"15","author":"N Ali","year":"2025","unstructured":"Ali, N., Akbar, R., Saleem, A., Ali, A. & Ali A. AI based natural inhibitor targeting RPS20 for colorectal cancer treatment using integrated computational approaches. Sci. Rep. 15, 24906 (2025).","journal-title":"Sci. Rep."},{"key":"45845_CR46","doi-asserted-by":"publisher","unstructured":"Liu, Y. T., Chen, Y. H., Chang, C. H. & Liang, H. K. T. Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature. Neuro-Oncology Adv. 6 https:\/\/doi.org\/10.1093\/noajnl\/vdae072 (2024).","DOI":"10.1093\/noajnl\/vdae072"},{"key":"45845_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12967-023-03955-5","volume":"21","author":"M Ganji","year":"2023","unstructured":"Ganji, M., Bakhshi, S., Shoari, A. & Ahangari Cohan, R. Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer. J. Translational Med. 21, 111. https:\/\/doi.org\/10.1186\/s12967-023-03955-5 (2023).","journal-title":"J. Translational Med."},{"key":"45845_CR48","doi-asserted-by":"publisher","unstructured":"Alsaiari, A. A. et al. From nature\u2019s pharmacy: harnessing bioactive phytoconstituents as fibroblast growth factor receptor 3 inhibitors for anti-cancer therapeutics. J. Biomol. Struct. Dyn. 1\u201312. https:\/\/doi.org\/10.1080\/07391102.2024.2435063 (2024).","DOI":"10.1080\/07391102.2024.2435063"},{"key":"45845_CR49","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.3390\/ijms241210337","volume":"24","author":"P Shi","year":"2023","unstructured":"Shi, P., Xu, J. & Cui, H. The Recent Research Progress of NF-\u03baB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma. Int. J. Mol. Sci. 24, 10337 (2023).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:23:40Z","timestamp":1779837820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45845-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]},"assertion":[{"value":"20 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors used GPT-5.2 solely to assist with language editing and improving the clarity of the manuscript. The AI tool was not used to generate scientific results, perform data analysis, interpret findings, or produce figures or tables. All computational analyses, results, interpretations, and conclusions presented in this study were independently performed, verified, and approved by the authors, who take full responsibility for the content of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI use declaration"}}],"article-number":"16370"}}